2020: The Year “The Dumb Money Was The Smart Money”
“The dumb money was the smart money this year,” is how one portfolio manager cited in today’s article sums up the wild swings experienced by…
Investing
With A Focus On Genomics, This Lesser-Known ETF Is Outperforming – And Now May Be The Time To Buy
The lesser-known ETF discussed in today’s article is already beating the market – up 185% year to date – and the author believes it will…
Treating Severe COVID-19 Could Be Just “The Tip Of The Iceberg” For This Biotech Up 38,000%
The small Swiss biotech firm featured in today’s article has been developing a drug that could help patients suffering from severe COVID-19 – and with…
Battle Of The “Strong Buy” Biotechs
BioXcel Therapeutics is a clinical-stage biopharmaceutical company that utilizes artificial intelligence to identify improved therapies in neuroscience and immuno-oncology. TG Therapeutics is a biopharmaceutical company…
3 Biotech Stocks Flying High In The Mid-Cap “Sweet Spot”
In regards to biotech’s bullish year, the author of today’s article notes that “The COVID-19 pandemic has put a fire under many lesser-known names, including…
High Growth And Reasonable Risk: 2 Biotech Stocks To Consider
“In such a volatile market, it is quite difficult to find reasonably safe and high-growth biotech stocks,” acknowledges the author of today’s article. Of course,…
2 Biotech ETFs To Monitor For Potential Breakouts – And Possible Trading Plays For Both
With the global biotechnology market expected, by one estimate, to almost double from its $448 billion level last year to $833 billion by 2027, today’s…
An Options Strategy For This COVID Vaccine Play With More Room To Run
When it comes to COVID-19 vaccine manufacturers, the author of today’s article notes “While it’s no surprise that investors have already bought into these companies,…
New Biotech Stocks To Watch – And More!
Companies involved in spectroscopy, bioelectronic medicine and telemedicine make up the three new biotech stocks to watch highlighted in today’s article, which also highlights new…
“Out Of Favor Healthcare Stocks Poised For Growth”: An Investing Theme For A Return To Normal
With the COVID-19 pandemic resulting in reduced doctor visits and delayed surgeries and procedures, many healthcare stocks have suffered this year. But as things begin…